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The importance of neuropeptide Y (NPY) and Y2 receptors in
the regulationof bone and energy homeostasis has recently been
demonstrated. However, the contributions of the other Y recep-
tors are less clear. Here we show that Y1 receptors are expressed
on osteoblastic cells. Moreover, bone and adipose tissue mass
are elevated in Y1/ mice with a generalized increase in bone
formation on cortical and cancellous surfaces. Importantly, the
inhibitory effects of NPY on bone marrow stromal cells in vitro
are absent in cells derived from Y1/mice, indicating a direct
action of NPY on bone cells via this Y receptor. Interestingly, in
contrast to Y2 receptor or germ line Y1 receptor deletion, con-
ditional deletion of hypothalamic Y1 receptors in adultmice did
not alter bone homeostasis, food intake, or adiposity. Further-
more, deletion of both Y1 and Y2 receptors did not produce
additive effects in bone or adiposity. Thus Y1 receptor pathways
act powerfully to inhibit bone production and adiposity by non-
hypothalamic pathways, with potentially direct effects on bone
tissue through a single pathway with Y2 receptors.
Many physiological functions are regulated by signals pro-
cessed within the brain. Y receptors, members of the G-pro-
tein-coupled receptor superfamily, play an important role in
this regulatory axis,mediated by their endogenous ligands: neu-
ropeptide Y (NPY),6 peptide YY, and pancreatic polypeptide.
TheY receptor system is complex, consisting of five Y receptors
(Y1, Y2, Y4, Y5, and y6), each with varying distributions across
peripheral and central tissues, including the hypothalamus.
Among a number of responsive tissues, both bone and adipose
tissue are known to be regulated, at least in part, via hypotha-
lamic Y2 receptors (1–4). Indeed, lack of central Y2 signaling,
as in hypothalamus-specific Y2 receptor conditional knock-out
mice, causes increased bone mass (1). Furthermore, deletion of
Y2 receptors has recently been demonstrated to decrease Y1
receptor expression in stromal cells, associated with a greater
population of progenitor cells, and accounting for the greater
synthetic activity of these cells in vitro suggesting an important
role of this Y receptor in bone formation as well (see the accom-
panying report (39).
Y1 receptors are widely expressed in the central nervous sys-
tem, including the hypothalamus (5, 6), as well as on peripheral
tissues such as vascular smooth muscle cells (7) and pancreatic
 cells (8). Y1 receptors are expressed on bonemarrow stromal
cells and bone tissue (see accompanying report (39)), by con-
trast, Y2 receptors have not been detected on bone. In addition
to effects in bone, Y1 receptors have been considered as impor-
tant regulators of energy homeostasis, consistent with pharma-
cological evidence from Y receptor agonists and antagonists to
stimulate or inhibit feeding (9). Fasting-induced re-feeding is
reduced in germ line Y1 receptor knock-out mice (10), and
deletion of Y1 receptors in genetically obese ob/ob mice, in
which hypothalamic NPY-ergic activity is chronically
increased, significantly reduces food intake and body weight
(11). Paradoxically, germ line Y1 receptor knock-out mice
develop late-onset obesity in the absence of hyperphagia (10,
12, 13). One hypothesis to reconcile this apparent discrepancy
is that hypothalamic and non-hypothalamic Y1 receptors have
different effects on energy homeostasis.
Given the clear involvement of Y1 receptors in the regula-
tion of energy homeostasis as well as new evidence of a puta-
tive role for Y1 receptors on osteoblast-like cells, we inves-
tigated the effect of germ line and conditional (adult-onset,
hypothalamus-specific) deletion of Y1 receptors in mice. In
addition, the potential interaction between Y1 receptor sig-
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naling and the previously identified Y2 receptor pathway was
assessed in Y1/Y2/ double knock-out mice.
EXPERIMENTAL PROCEDURES
Animal Care—All research and animal care procedures were
approved by the Garvan Institute/St. Vincent’s Hospital Ani-
mal Experimentation Ethics Committee andwere in agreement
with the Australian Code of Practice for the Care and Use of
Animals for Scientific Purpose. All mice were fed a normal
chow diet ad libitum (6% calories from fat, 21% calories from
protein, 71% calories from carbohydrate, 2.6 kilocalories/g,
Gordon’s Specialty Stock Feeds, Yanderra, New South Wales,
Australia), with ad libitum access to water.
Generation of Y1/ and Y1/Y2/ Double Mutant Mice
—A targeting vector for the Y1 and Y2 receptor genes (Npy1r
and Npy2r, respectively) has been used to produce both germ
line (Y1/ or Y2/) and conditional (floxed, Y1lox/lox or
Y2lox/lox) knock-out mice, as previously published (2, 14). Both
of these knock-out strategies result in deletion of the entire
coding region of the Y1 or Y2 receptor, including the neomycin
selection cassette. Germ line Y1/ and Y2/ lines were bred
to generate double heterozygotemice, whichwere then crossed
to obtain the double knock-out mouse line. All mice were on a
mixed C57BL/6–129/SvJ background.
Generation of Adult-onset Hypothalamus-specific Y1 Recep-
tor Knock-out Mice (Y1Hyp)—9- to 10-week-old Y1lox/lox mice
were anesthetized with 100/20 mg/kg ketamine/xylazine
(Parke Davis-Pfizer, Sydney, Australia and Bayer AG,
Leverkusen, Germany). With the head in the flat skull position
using a stereotaxic table (David Kopf, Tujunga, CA), brain
injection coordinates relative to Bregma were posterior 0.8
mm, lateral  0.5 mm, ventral 4.7 mm, corresponding to the
paraventricular nucleus of the hypothalamus (15). 0.5 l of
virus (1 109 plaque-forming units/l) was injected bilaterally
over 10 min using a 26-gauge guide cannula and a 33-gauge
injector (PlasticsOne, Roanoke, VA) connected to a Hamilton
syringe and a syringe infusion pump (World Precision Instru-
ments, Sarasota, FL). Injection with adeno-associated viral vec-
tor (rAAV) expressing Cre-recombinase produced hypothala-
mus-specific Y1 receptor knock-out mice (Y1Hyp). Control
Y1lox/lox mice were injected with virus carrying an empty
adeno-associated viral vector and are referred to as Y1lox/lox.
Mice were housed individually for the ensuing 9 weeks, and
body weight was measured three to five times per week at the
same time of day.
Temperature Measurements—At 5 weeks after rAAV vector
injection, body temperature was measured at 9.00 h with a
rectal thermometer (Physitemp Instruments Inc., Clifton, NJ).
Temperature readings were taken within 10 s of removing the
mouse from its cage. Repeat readings were taken from each
mouse on 3 consecutive days, and the average of the three read-
ings was used for statistical analysis.
Feeding and Behavioral Studies—At 6 weeks after rAAV vec-
tor injection, mice were transferred from housing on soft bed-
ding to cageswith only a single paper towel on the bottomof the
cage and allowed to acclimatize for 3 nights. 24-h food and
water intake were determined as the average of triplicate read-
ings taken over 3 consecutive days. Actual food intake was cal-
culated as the weight of pellets taken from the food hopper
minus the weight of food spilled in the cage. Fecal weight was
also determined in triplicate during these analyses. Wild-type
mice housed on paper toweling typically used this to build a
nest. This “nesting behavior” was quantified by weighing the
amount of paper towel that had been shredded. 7 weeks post
injection, the effect of 24 h fasting on body weight was deter-
mined. Food and water consumption, food spillage, and fecal
outputwere determined as described above after 1 and 2 days of
re-feeding, and body weight was also tracked during the first 3
days of re-feeding. Mice were then returned to soft bedding.
Glucose Tolerance Tests—At 8 weeks after rAAV vector
injection,micewere fasted for 24 h before intraperitoneal injec-
tion of a 10% D-glucose solution (1.0 g/kg) with tail blood sam-
pling (20–50 l) at 0, 15, 30, 60, and 120 min after injection.
Serum was stored at20 °C for subsequent analysis.
Tissue Collection—Mice were injected with the fluorescent
compound calcein (15 mg/kg, Sigma) 10 and 3 days prior to
tissue collection to enable subsequent calculation of bone for-
mation rate. Y1Hyp mice and Y1lox/lox controls were culled at
18–19weeks of age, 9 weeks after rAAV vector injection. Germ
line Y1/, Y2/, and Y1/Y2/ mice and wild-type con-
trols were culled at 15–17 weeks of age. Mice were culled in the
freely fed state between 12:00 noon to 3:00 p.m. by cervical
dislocation followed by decapitation for collection of trunk
blood. Serum was collected and stored at 20 °C until subse-
quent analysis as described below. The interscapular brown
adipose tissue (BAT) as well as white adipose tissue (WAT)
depots (right inguinal, right epididymal or periovarian
(gonadal), right retroperitoneal, andmesenteric) were removed
and weighed. The weight of these WAT depots were summed
together and expressed as total WAT weight, normalized as a
percentage of body weight. Both femurs and the caudal verte-
brae were excised and fixed in 4% paraformaldehyde for 16 h at
4 °C.
Bone Histomorphometry—The right femur was bisected
transversely at the midpoint of the long axis, the distal half was
embedded undecalcified inmethacrylate resin (Medim-Mediz-
inische Diagnostik, Giessen, Germany), and 5-m sagittal sec-
tions were analyzed, as previously described (16). The 4th cau-
dal vertebra was sectioned in the sagittal plane, and mid
vertebral sections were analyzed as previously described (17).
Briefly, sections were stained for mineralized bone, and trabe-
cular bone volume, thickness, and trabecular numbers were
calculated. Bone formation (mineralizing surface), mineral
apposition rate, and bone formation rate were calculated, as
previously described (16) using fluorescence microscopy
(Leica, Heerbrugg, Switzerland). Osteoclast surface and oste-
oclast number were estimated using tartrate-resistant acid
phosphatase-stained sections, with only multinucleated, tar-
trate-resistant acid phosphatase-positive cells associated with
the bone surface being included in the analysis. Cortical min-
eral apposition rate was measured on the anterior periosteal
surface in a region extending 1000 m distal from the mid-
point and in an endosteal region extending 1000 m proximal
from the posterior aspect of the growth plate, as previously
described (18).
Bone and Adipose Effects of Y1 Knockout
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Bone Densitometry—Whole femoral bone mineral content
and bone mineral density were measured using a dedicated
mouse dual x-ray absorptiometer (Lunar Piximus II, GE Medi-
cal Systems, Madison, WI) in excised left hind limbs. Femurs
were scanned with tibiae attached and the knee joint in flexion
to 90°, to ensure consistent placement and scanning of the sag-
ittal profile.
Quantitative Computed Tomography—Quantitative com-
puted tomography was used to isolate cortical bone for analysis
inmalemice, using a Stratec XCTResearch SA (StratecMediz-
intechnik, Pforzheim, Germany). Scans were conducted using a
voxel size of 70m, scan speed of 5mm/s, and slice width of 0.2
mm every 0.5 mm on excised left femurs, as previously
described (16). Bones were scanned in two consecutive slices, 7
and 7.5 mm from the distal margin of the femur, representing a
mid femoral aspect. Bone strength index, an indicator of bend-
ing strength, was calculated (18).
Serum Analyses—Hormone levels in serum samples col-
lected at cull were determined with commercial radioimmu-
noassay kits: insulin (Linco Research, St. Louis, MO), corti-
costerone, free T4 (ICN Biomedicals, Costa Mesa, CA), and
insulin-like growth factor-1 (Bioclone Australia, Marrick-
ville, New SouthWales, Australia). Basal and glucose-induced
serum glucose and insulin levels were determined with a glu-
cose oxidase kit (Trace Scientific, Melbourne, Australia) and
insulin with an enzyme-linked immunosorbent assay kit from
Linco Research, respectively.
Gene Expression in Mouse Calvarial Osteoblast Cultures—
Bone cells were isolated from calvariae of 2- to 3-day-old CsA
mice using a modified time sequential enzyme-digestion tech-
nique (19). Cells frompopulations 6 to 10were used. These cells
showed an osteoblastic phenotype as assessed by their cAMP
responsiveness to parathyroid hormone, expression of alkaline
phosphatase, osteocalcin and bone sialoprotein, and the capac-
ity to formmineralized bone noduli (data not shown). The cells
were seeded in culture flasks containing -minimal essential
medium supplemented with 10% fetal calf serum, L-glutamine,
and antibiotics at 37 °C in humidified air containing 5% CO2.
After 4 days in flasks, the cells were seeded in culture dishes.
Osteoblasts were plated at a density of 104 cells/cm2 in culture
dishes containing -minimal essential medium/10% fetal
bovine serum. After attachment overnight, medium was
changed to -minimal essential medium/10% fetal bovine
serum. After 7 days of culture, RNAwas extracted and used for
quantitative real-time reverse transcription-PCR analyses.
RNA Extraction and cDNA Synthesis—Total RNA was
extracted from mouse calvarial osteoblasts using the
RNAqueous-4PCR kit following the manufacturer’s proto-
col (Ambion Inc., Austin, TX). The RNA was quantified
spectrophotometrically, and the integrity of the RNA prep-
arations was examined by agarose gel electrophoresis.
Extracted total RNA was treated with deoxyribonuclease I to
eliminate genomic DNA according to manufacturer instruc-
tions. One microgram of total RNA, following DNase treat-
ment, was reverse transcribed into single-stranded cDNA
with a 1st Strand cDNA Synthesis Kit using oligo-p(dT)15
primers. After incubation at 25 °C for 10 min and at 42 °C for
60 min, the avian myeloblastosis virus reverse transcriptase
was denatured at 99 °C for 5 min, followed by cooling to
4 °C for 5 min. The cDNAwas kept at20 °C until used for
PCR.
Quantitative Real-time PCR—Expression of Y1 and Y2
receptor mRNA were analyzed by quantitative real-time PCR
using the TaqMan Universal PCR master mix (Applied Biosys-
tems, Foster City, CA) and a sequence detection system (ABI
Prism 7900 HT Sequence Detection System and Software,
Applied Biosystems) with fluorescence-labeled probes
(reporter fluorescent dye VIC at the 5-end and quencher fluo-
rescent dye tetramethylrhodamine at the 3-end). Primers and
probes for Y1 and Y2 receptors were analyzed using a kit from
Applied Biosystems. To control for variability in amplification
due to differences in starting mRNA concentrations, -actin
was used as an internal standard. The specific primers and
probes used are as follows for -actin (sense: 5-GGACCT-
GACGGACTACCTCATG-3, antisense: 5-TCTTTGATGT-
CACGCACGATTT-3, probe: 5-CCTGACCGAGCGTGGC-
TACAGCT TC-3). The relative expression of target mRNA
was computed from the target Ct values and the -actin Ct
value using the standard curve method (User Bulletin 2,
Applied Biosystems).
Isolation and Culture of Bone Marrow Stromal Cells—Bone
marrow stromal cells were isolated from 5- to 9-week-old
male wild-type and germ line Y1/ mice as previously
described (see accompanying report (39)). Briefly, marrow
was flushed from femurs and tibias with control media, and
cells were plated at a density of 1.9 106 cells/cm2 in 50-cm2
plastic tissue culture plates. The non-adherent cell popula-
tion was removed by medium changes 3 and 5 days later.
Cells were trypsinized after 7 days in culture with 0.25%
trypsin containing 0.53 mM EDTA and re-plated at 3  104
cells/cm2 in 24-well plates in either control media or control
media containing 100 nM human NPY (Auspep, Parkville,
Victoria, Australia). After an additional 5 or 20 days in cul-
ture, cells were trypsinized, and viable cell numbers were
determined by trypan blue staining.
FIGURE 1. Sagittal micrographs of the distal femoral metaphysis of (B)
germ lineY1/malemice comparedwith (A) wild-typemale controls or
(D) male mice 9 weeks after hypothalamic injection of Cre-expressing
rAAV vector to induce adult-onset hypothalamus-specific Y1 receptor
deletion (Y1Hyp) compared with (C) control mice injected with empty
AAV vector (Y1lox/lox). Shown are darkly stained bone tissues representative
of the respective groups. Bar, 1 mm.
Bone and Adipose Effects of Y1 Knockout
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Statistical Analyses—All data are expressed as mean  S.E.
Differences between two groups were assessed by two-tailed
Student’s t test. Differences among multiple groups of mice
were assessed by analysis of variance or repeated measures
analysis of variance, followed by Fisher’s or Contrast post-hoc
comparisons if appropriate (StatView version 4.51 or Super-
ANOVA, Abacus Concepts Inc., Berkeley, CA). Statistical sig-
nificance was defined as p 0.05.
RESULTS
Greater Bone Formation in Y1 Receptor Null Mice
To examine the mechanism behind the elevation in bone
mass evident in Y1/mice (see accompanying report (39)), we
examined distal femurs and caudal vertebrae from skeletally
mature male and female mice.
Cancellous Bone—Germ line Y1/ mice displayed signifi-
cantly greater cancellous bone volume in the distal femoral
metaphysis, with greater trabecular number and thickness
(Figs. 1 and 2). Interestingly, this was associated with increased
activity of both osteoblastic and osteoclastic lineages. Similar to
Y2/ mice, bone formation rate was greater in Y1/ mice
compared with wild-type mice with enhanced mineral apposi-
tion rate (MAR) in both sexes, but no change in mineralizing
surface (Fig. 2). However, in contrast to Y2/ mice, bone
resorption was also altered in Y1/ mice, with significantly
greater osteoclast surface in both sexes (Fig. 2).
These changes in cancellous bone homeostasis were also evi-
dent in the caudal vertebrae. At this site, cancellous bone vol-
ume was significantly increased in knock-out mice compared
with wild-type values (Y1/, 30.9  1.2% versus wild type,
25.5  2.4%, n  5–9 male mice, p  0.05). As in the femurs,
this change was also associated with greater trabecular thick-
ness (Y1/, 65.4 2.0m versuswild type, 44.0 2.9m, p
0.0001). These cancellous changes are consistent with the pre-
viously noted elevation in bone mineral density and content in
Y1/ long bones; however, because cortical bone rather than
FIGURE 2.Cancellous bone phenotype in the distal femoralmetaphysis ofmale and female germ line Y1/mice. Changeswere consistent across both
sexes, with lack of Y1 signaling resulting in greater cancellous bone volume (A and H), trabecular number (B and I), and trabecular thickness (C and J). These
changes in bone were coincident with greater bone formation rate (D and K) due to greater mineral apposition rate (E and L) with no change in mineralizing
surface (F andM). The cancellous bone surface covered by bone-resorbing cells was also altered, with osteoclast surface greater in Y1/ compared with wild
type (G and N). Data are means S.E. of 13–18male mice and 10–13 female mice per group. *, p 0.05; **, p 0.01; and ***, p 0.001 versuswild-typemice
of the same gender.
FIGURE 3. Cortical bone phenotype in themid-femoral diaphysis ofmale
germ lineY1/mice.Corticalmineral content (A)was greater inY1/mice
comparedwithwild-typemice, with no change in corticalmineral density (B).
This was coincident with greater cortical bone area (C) and thickness (D).
Strength indices were also altered, with polar moment of inertia (E) and cal-
culated strength index (F) greater in Y1/ compared with wild-type mice.
Data are means S.E. of six to eight male mice per group. *, p 0.05 versus
wild type.
Bone and Adipose Effects of Y1 Knockout
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cancellous bone is the major con-
tributor to changes in bone density
and content, the cortical content of
bones from Y1/mice was further
examined.
Cortical Bone—Cortical changes
in Y1/ long bones were examined
by quantitative computed tomogra-
phy. At the mid-femur, Y1/mice
had greater cortical mineral content
and density, consistent with
greater cortical area and thickness
(Fig. 3). Polarmoment of inertia and
strength index were also signifi-
cantly greater in the femoral cross-
sections of Y1/ compared with
wild-type mice (Fig. 3). The
observed increase in cortical min-
eral content in Y1/ mice com-
bined with the 25% increase in
strength index indicate a response
sufficient to produce functional rel-
evant changes in bone strength in
vivo and highlights the therapeutic
potential of such pathways.
To further investigate the cellular
basis for these differences, both
endocortical and periosteal surfaces
were examined. Cortical osteoblast
activity was increased in Y1/
mice, with MAR elevated on the
femoral endosteal surface an aver-
age of 70% in both genders and on
the periosteum of male Y1/mice
with an increase of nearly 7-fold
(Fig. 4). Taken together, these data
reveal that loss of Y1 receptor sig-
naling results in a generalized eleva-
tion in parameters of osteoblast
activity, at both axial and appendic-
ular sites leading to greater cancel-
lous and cortical bone accrual.
Sustained Elevation of Adiposity in
Y1ReceptorNullMice—Bodyweight
and adiposity of young and aged
Y1/ mice were compared with
age-matched wild-type controls to
determine progression of the Y1/
energy homeostasis phenotype.
Both male and female Y1/ mice
developed an obese phenotype with
advancing age (Fig. 5), indicated by
significantly greater body weight,
WAT and BAT depots, and with a
more pronounced phenotype in
female Y1/ mice. These changes
in body weight were not due to
changes in stature, because femur
FIGURE 4. Cortical bone formation in femurs of germ line Y1/mice. Endosteal mineral apposition rate
(MAR) was greater in both sexes of Y1/mice (A and C), with periosteal MAR greater in males only (B and D).
Data aremeans S.E. of five to sevenmale and sevenor eight femalemiceper group. Photomicrographs show
calcein label apposition on the periosteal surface of male wild-type (E) and Y1/ (F) mice, with an interlabel
interval of 7 days. Bar, 12 m. *, p 0.05 versuswild-type mice of the same gender.
FIGURE 5. Changes in body weight (A and D) and adiposity (B, C, E, and F) of young (15–17 weeks) and
aged (46–52 weeks) male and female germ line Y1/mice. Themass of WAT depots (right inguinal, right
epididymal or right periovarian, right retroperitoneal, and mesenteric), expressed as a percentage of body
weight,were summed (Band E).Cand F, BAT.Data aremeansS.E. of at least 15youngandat least 7 agedmice
per group. *, p 0.05; **, p 0.01; and ***, p 0.001 versus the comparison shown by horizontal bars.
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length was not significantly different between Y1/mice and
wild type (data not shown). Thus, whereas wild-type mice
showed no changes in body weight and adiposity with age
beyond 12months, Y1/mice showedmarked and significant
increases, indicating a sustained and continuing effect on
energy homeostasis and adipocyte function in these mice.
To gain insight into possible mechanisms of obesity associ-
ated with Y1 deficiency, we measured metabolic parameters
and energy expenditure in Y1/ mice. There was no signifi-
cant effect of genotype on serum concentrations of corticoster-
one, glucose, insulin-like growth factor 1, and free T4 and tem-
perature (data not shown); however, serum insulin levels were
significantly higher in Y1/mice (female Y1/, 177 27 pM
versus wild type, 56  7 pM, n  17, p  0.001; male Y1/,
220 52 pM versus wild type, 120 18 pM, n 18, p 0.05).
Because insulin is lipogenic (20–22), it is possible that these
higher serum insulin levelsmay be causally linked to the greater
adiposity observed in young and aged germ line Y1/mice.
Interestingly, and in contrast to the elevated adiposity,Y1/
mice displayed significant reductions in food intake at 1, 2, and
8 h after re-introduction of food following 24-h fasting (e.g.
femaleY1/, 0.95 0.12 g/2 h versuswild type, 2.12 0.36 g/2
h, n  4, p  0.01; male Y1/, 1.33  0.16 g/2 h versus wild
type, 2.30  0.33 g/2 h, n  4, p  0.01), whereas no such
reduction in food intake was apparent in Y1/ mice in the
non-fasted state or beyond 24 h of re-feeding.
Hypothalamic Y1 Receptors Do Not Regulate Bone Mass—
Previously we showed that hypothalamus-specific Y2 recep-
tor deletion leads to pronounced anabolic effects on bone
(1). We therefore hypothesized that the phenotype observed
in the bones of germ line Y1/ mice might also involve
signals mediated by the hypothalamus. To test this, we inves-
tigated bone homeostasis in mice with adult-onset, hypo-
thalamus-specific deletion of Y1 receptors. Localized Y1
receptor deletion in the hypothalamus was verified by PCR
on genomic DNA extracted from the hypothalamus, with
forebrain and liver of rAAV vector-injected mice used as
negative controls. PCR primers were designed to produce a
detectable product only when the Y1 receptor had been
deleted. This was the case only in amplified DNA extracted
from the hypothalamus of virus-injected Y1lox/lox mice but
not in DNA from control samples (data not shown), confirm-
ing the successful ablation of Y1 receptor genes in this area.
Cancellous Bone—Deletion of hypothalamic Y1 receptors
from adult mice (Y1Hyp) did not alter cancellous bone volume
comparedwith age-matchedY1lox/lox controls of either sex (Fig.
1 and Table 1). Importantly, and consistent with the lack of
change in cancellous bone volume, hypothalamus-specific
deletion of Y1 receptors did not alter bone cell activity. Mineral
apposition rate and osteoclast surface and number were not
different between Y1Hyp and Y1lox/lox controls of either gender
(Table 1).
Cortical Bone—Similarly, quantitative computed tomogra-
phy analysis revealed no difference in cortical bone between
Y1Hyp and Y1lox/lox groups, with no change in femoral BMC
in males (Y1Hyp, 1.28  0.03 g versus Y1lox/lox, 1.29  0.03 g,
n  3–5) or females (Y1Hyp, 1.17  0.02 g versus Y1lox/lox,
1.15 0.04 g, n 3–5). Femoral bonemarrow density was not
different in males (Y1Hyp, 758  13 mg/mm2 versus Y1lox/lox,
754 10 mg/mm2, n 3–5) or females (Y1Hyp, 766 7 versus
Y1lox/lox, 747  6 mg/mm2, n  3–5). No change in cortical
mineral content, density, or architecture was observed (data
not shown). These findings demonstrate that Y1 receptors in
this part of the brain are not responsible for the marked effects
of germ line Y1 receptor knock-out on bone and further indi-
cate a peripheral, possibly direct, site of action.
Y1 Receptor Mediates Direct
Effects of NPY on BoneMarrow Stro-
mal Cell Number—To investigate
the possibility that Y1 receptors
influence bone tissue via direct
effects, Y1 receptor expression
was investigated in mouse calvar-
ial osteoblasts expressing the
osteoblastic marker genes alkaline
phosphatase, osteocalcin, and
bone sialoprotein, and demon-
strating the capability of forming
mineralized bone noduli (data not
shown). Quantitative real-time
PCR revealed that Y1 receptor
gene transcripts were present in
osteoblasts at day 7 of culture (Fig.
6A). Expression of Y2 receptors was
FIGURE 6. Expression of Y1 and Y2 receptormRNA.Graph showing quantitative real-time reverse transcrip-
tion-PCR analysis of Y1 receptor expression in mouse calvarial osteoblasts (A). The values shown are quantity
(Qt) of Y1 receptor mRNA normalized to that of -actin. Data are mean n 5 S.E. B, effect of NPY treatment
on the number of viable bonemarrow stromal cells fromwild-type and Y1/mice. Treatment of cultureswith
100nMNPYsignificantlydecreasedcell number in thewild-typeculturesbutnot in culturesderived fromY1/
mice. p 0.01 versus the comparison shown.
TABLE 1
Cancellous bone parameters in the femur following adult-onset
hypothamus-specific deletion of Y1 receptors (Y1Hyp) compared
to control mice with Y1 receptors intact (Y1lox/lox)
Data are means S.E. of three to five male and seven to ten female mice per group.
At p 0.05, no significant differences were detected in within-gender comparisons.
Genotype/
gender
Cancellous
bone
volume
Mineral
apposition
rate
Osteoclast
surface
Osteoclast
number
% m/d % /mm
Male
Y1lox/lox 8.0 0.7 2.24 0.1 13.0 0.5 4.5 0.3
Y1Hyp 7.0 2.0 1.98 0.2 14.3 2.2 5.2 0.8
Female
Y1lox/lox 7.2 0.8 2.63 0.1 12.1 1.1 3.9 0.3
Y1Hyp 9.4 0.9 2.48 0.1 12.5 1.2 3.9 0.4
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not detected. These data are consistent with a direct, Y1-medi-
ated effect in these cells. To further investigate this possibility,
the effect of NPY treatment on cultured bone marrow stromal
cells from wild-type and Y1/ mice was examined. Adminis-
tration of NPY to cultures from wild-type tissue markedly
reduced cell numbers (Fig. 6B). Cell numbers in Y1/ cultures
were comparable to those of wild-type control cultures and
were not altered byNPY treatment, providing the first evidence
of direct, Y1-mediated regulation of this system.
Hypothalamic Y1ReceptorsDoNotAlter EnergyHomeostasis—
Hypothalamic Y1 receptors are hypothesized to mediate ana-
bolic effects, namely hyperphagia, under conditions of elevated
hypothalamic NPY levels such as fasting or genetic obesity (10,
11). We investigated energy homeostasis in Y1Hypmice but did
not see significant differences from control Y1lox/lox mice with
respect to body weight in the first 6 weeks after rAAV vector
injection, at time of cull 9 weeks after vector injection, or in
response to 24-h fasting and 72-h re-feeding (Fig. 7 and Table
2). The actual food intake of Y1Hypmice was not significantly
different from that of control mice (Fig. 7), either in the
non-fasted state or in the first 2 days of re-feeding after a
24-h fast. In keeping with a lack of effect of hypothalamic Y1
receptor deletion on food intake, water intake and fecal out-
put were not significantly different between Y1Hyp and
Y1lox/lox mice (Table 2).
Some factors that regulate energy homeostasis do so by alter-
ing fat mass or glucose metabolism even in the absence of
effects on body weight or food intake (10, 21, 23, 24).We there-
fore investigated whether hypothalamic Y1 receptor knock-out
induced alterations in fat mass or glucose homeostasis. Y1Hyp
mice showed no significant difference from Y1lox/lox mice with
respect to WAT and BAT depots or rectal temperature (Table
2), suggesting no change in thermogenesis. In addition, there
was no significant effect on fasting serum glucose or insulin
levels or the change in serum glucose or insulin levels in
response to intraperitoneal glucose injection, albeit the area
under the insulin curve after glucose injection tended to be
higher in knock-out than in wild-type mice (Table 2).
The conditional deletion of Y1 receptors in adult mice has, for
the first time, enabled examination of the role of these signals in
FIGURE 7. Effect of hypothalamus-specific Y1 receptor deletion on non-fasted and fasting-induced body weight, feeding, and nesting behavior.
Region-specific Y1 receptor knock-out, in the hypothalamus (Y1Hyp) on day 0, had no significant effect on body weight (A and B) compared with control mice
(Y1lox/lox). Shown are the percent bodyweight values lost during 24-h fasting and 72-h re-feeding (C andD) and feeding behavior incorporating the amount of
food taken from the food hopper but spilled on the cage floor as well as the amount of food actually eaten, either in the non-fasted state (before fasting) or in
the first 48 h of re-feeding (E and F). G, nesting behavior, quantified as the weight of paper toweling shredded per day. Data in panels C–Gwere collected at 7
weeks after adenoviral vector injection. Data aremeans S.E. of four or fivemale and seven to ten femalemiceper group. *,p 0.05 versus the amount of food
spilled or the amount of paper toweling shredded by control (Y1lox/lox) mice of the same gender and of the same nutritional status (non-fasted or re-fed).
TABLE 2
Effect of hypothalamus-specific deletion of Y1 receptors on parameters of energy balance in adult mice
Data are means S.E. of three to five male and seven to ten female mice. At p 0.05, no significant differences were detected in within-gender comparisons.
Genotype Bodyweight
Water
intake
Fecal
output
WAT
weight
BAT
weight
Rectal
temperature
Fasting
serum
glucose
Area under
glucose tolerance
curve (glucose)
Fasting
serum
insulin
Area under
glucose tolerance
curve (insulin)
g ml/day g/day % BWTa % BWT °C mM mMx90 pM pMx90
Male
Y1lox/lox 27.2 1.3 3.5 0.2 0.83 0.05 2.8 0.3 0.29 0.02 35.74 0.3 5.0 1.1 670 90 62 2 8,520 440
Y1Hyp 27.0 3.8 4.2 0.8 0.76 0.08 3.9 1.4 0.44 0.16 35.73 0.3 6.5 0.8 750 200 80 17 10,640 40
Female
Y1lox/lox 19.6 0.4 4.0 0.4 0.64 0.03 3.0 0.2 0.33 0.03 36.11 0.2 5.3 0.4 730 50 89 6 11,180 570
Y1Hyp 20.9 0.9 4.7 0.3 0.60 0.04 3.0 0.5 0.27 0.02 36.51 0.2 5.0 0.6 810 80 97 13 13,040 710
a %BWT, percent body weight.
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energy homeostasis. In a similar manner to skeletal effects, the
regulationof energyhomeostasis and food intakebyY1 is not con-
trolled by those hypothalamic receptors that were deleted in the
current study, indicating a consistent pattern of non-hypotha-
lamic Y1 action in the regulation of these processes.
However, hypothalamic Y1 receptor knock-out did alter spe-
cific aspects of behavior in relation to feeding. Food grinding
was markedly increased in these mice, with the amount of
ground food spilled on the cage floor significantly elevated in
both male and female Y1Hyp mice compared with controls
(Fig. 7).
Hypothalamic Y1 Receptors Modify Behavior—Interestingly,
although hypothalamus-specific Y1 receptor deletion had no
impact on parameters of energy homeostasis, it significantly
influenced a related maternal behavior, showing a loss of
nest-building abilities. Whereas control Y1lox/lox mice con-
sistently used the paper towel provided as bedding material
for constructing a nest, this behavior was completely absent
in Y1Hyp mice. Indeed, the measured weight of shredded
paper, as an indicator for nesting behavior, was dramatically
reduced in both male and female Y1Hyp versus Y1lox/lox con-
trol mice (Fig. 7).
Coincident Deletion of Y1 and Y2 Receptors Does Not Induce
Additive Changes in Bone
Cancellous Bone—Our previous study revealed a Y2-depend-
ent inhibition of Y1 expression in osteoblastic and adipocytic
lineage cells (see accompanying report (39)), thereby suggesting
a putative mechanism whereby central Y2 signaling modulates
peripheral tissue homeostasis. To gain further insights into
whether Y1 and Y2 receptors are linked in the regulation of
bone physiology, we generated Y1/Y2/ receptor double
knock-out mice and investigated whether additive effects were
apparent. Importantly, although Y1/Y2/ receptor double
knock-out mice of both genders had significantly greater can-
cellous bone volume compared with wild-type controls (Fig. 8),
there were no significant differences from Y1/ and Y2/
mice. Mineral apposition rate was significantly increased in all
three Y receptor-deficient models compared with wild-type
mice. There were however, someminor differences, withMAR
inmaleY1/Y2/mice significantly reduced comparedwith
Y2/mice. Unlike Y1/mice, Y1/Y2/mice showed no
increase in osteoclast surface (Fig. 8). Thus, whereas double
deletion of Y1 and Y2 receptors induces significant effects on
cancellous bone, there were no obvious additive effects over
those of Y1 or Y2 receptor deletion in isolation.
Cortical Bone—Similarly, quantitative computed tomogra-
phy analysis revealed thatY1/Y2/ femurs had significantly
greater cortical bone area and thickness than wild-type mice,
although therewas no significant effect on corticalmineral con-
tent or density (Fig. 9). As in theY1/ andY2/ single knock-
out models, these architectural changes were coincident with
greater cortical bone formation in Y1/Y2/ mice, with
endosteal MAR elevated compared with wild type (Fig. 9). The
strength index of femurs from Y1/Y2/ double knock-out
micewas comparable to those in singleY1/ orY2/ animals
(Fig. 9). Although a common feedback control for independent
pathways cannot be ruled out, the lack of additive responses in
FIGURE 8. Cancellous bone phenotype in the distal femoral metaphysis of male and female germ line Y1, Y2, and Y1/Y2/ receptor double
knock-out mice. Changes were consistent across both sexes, with lack of Y1 receptor signaling resulting in greater cancellous bone volume (A and F) and
trabecular thickness (C and H) with trabecular number (B and G) greater in Y1/ and Y2/mice only. These changes were coincident with greater mineral
apposition rate (D and I). Parameters of bone resorption were also altered, with osteoclast surface (E and J) greater in Y1/mice compared with wild-type
controls. Data aremeans S.E. of 13–18male and 10–13 femalemice per group. *, p 0.05; **, p 0.01; and ***, p 0.001 versuswild-typemice of the same
gender; ‡, p 0.05 versus Y1/mice of the same gender.
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Y1/Y2/mice is consistent with a common pathway from
the hypothalamus to bone involving both Y2 and Y1 signaling.
DISCUSSION
In this study we show that Y1 receptors exert powerful con-
trol over bone production and have significant effects on adi-
posity. These findings indicate that these effects are most likely
mediated by non-hypothalamic Y1 receptors. Germ line dis-
ruption of Y1 receptor signaling revealed a generalized increase
in osteoblast activity on both cancellous and cortical surfaces,
with consistent changes in femoral, tibial, and vertebral bones.
Expression of Y1 receptors on osteoblastic and bone marrow
stromal cells suggested a peripheral, possibly directmechanism
of action. In keeping with this, deletion of hypothalamic Y1
receptors did not alter bone homeostasis and direct action of Y1
signaling was confirmed ex vivo in bone marrow stromal cell
cultures, where the NPY-mediated inhibition of cell number
was absent in Y1/ cells. These findings are consistent with
our previous study, with reduced expression of Y1 receptors in
stromal cells associated with a greater number of mesenchymal
progenitor cells in Y2/mice (see accompanying report (39)).
Moreover, a common pathway controlling bone formation by
Y1 and Y2 receptor subtypes was suggested by a lack of additive
effects on bone in Y1/Y2/mice.
In addition, adiposity was significantly elevated in young and
aged Y1/ mice, in association with significant decreases in
fasting-induced hyperphagia and increases in serum insulin
levels. Because insulin is lipogenic, promoting partitioning of
fuels toward WAT and away from muscle (20, 22), the hyper-
insulinemia observed in germ line Y1 knock-out mice could
contribute to the increased adiposity observed in these animals
despite the lack of hyperphagia. As with effects on bone, these
changes in food intake and adiposity were not evident in mice
following adult-onset deletion of hypothalamic Y1 receptors,
indicatingmediation of these effects by Y1 receptors other than
those hypothalamic receptors that were deleted in the current
study. Although hypothalamic Y1 receptors are not likely
involved in regulation of bone or adipose tissue nor of non-
fasted or fasting-induced food intake or body weight, they pro-
foundly influenced feeding and nesting behaviors, with hypo-
thalamus-specific Y1 receptor knock-out mice showing
marked increases in food grinding behavior and a pronounced
lack of nest-building behavior. Overall, these findings indicate a
generalized and powerful peripheral action of Y1 signaling in
the regulation of bone and adipose tissue.
Current understanding of the role of the NPY system in the
regulation of bone tissue and energy balance is rapidly expand-
ing. Y2 receptors have been established as significant regulators
of both bone and adipose tissue, with Y2 receptor knock-out
enhancing bone formation and reducing adiposity (1, 2, 25, 26).
Coincident deletion of Y2 andY4 receptors enhanced effects on
bone and adipose tissue, with Y2/Y4/ knock-out mice
showing even more pronounced increases in bone mass and
FIGURE 9. Cortical bone phenotype in themid-femoral diaphysis ofmale germ line Y1, Y2, and Y1/Y2/ receptor double knock-outmice. Cortical
mineral content (A) was greater in Y1/ and Y2/mice compared with wild type. Compared with wild-typemice, cortical mineral density (B) was greater in
Y2/mice only. Cortical bone area (C) and cortical thickness (D) were greater in all Y receptor-deficientmice, coincident with greater cortical bone formation,
with endosteal mineral apposition rate (MAR, E) greater in all Y receptor-deficientmice. Strength indices were altered, with polarmoment of inertia (F) greater
in Y1/ and Y2/mice and calculated strength index (G) greater in all Y receptor-deficientmice comparedwith wild-type controls. Data aremeans S.E. of
six to eight mice per group. *, p 0.05; **, p 0.01; and ***, p 0.001 versuswild-type mice; ‡, p 0.05 versus Y2/mice.
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synergistic decreases in adiposity (3).Wenowdemonstrate that
loss of Y1 receptor signaling also altered bone tissue and energy
homeostasis; however, the changes show important differences
from Y2/ or Y2Y4/mice, revealing unique actions of indi-
vidual Y receptors. Loss of Y1 signaling led to an increase in
adipose deposition, the opposite to that evident in lean Y2/
and Y2Y4/ mice. The regulation of fat and bone are to a
certain extent related by the actions of leptin, acting in the
hypothalamus to decrease adiposity and cancellous bone for-
mation (27–29). This relationship is evident in Y2Y4/mice,
whose lean phenotype and consequently reduced serum leptin
is a likely mechanism for the increased bone volume compared
with Y2/ mice (3). Similarly, the obesity evident in Y1/
micemight be expected to affect bone volume through action of
increased circulating leptin concentrations. However, as previ-
ously shown, despite greater fat mass, serum leptin levels are
not increased in our Y1/mice and indeed are not altered in
Y2/ or Y1/Y2/mice (13), suggesting that the leptin and
NPY-mediated pathways act separately in this model, as in pre-
vious studies (3, 16, 25).
Given the central nature of Y2-mediated effects on energy
homeostasis (2), the Y1-deficient phenotype was also assessed
by conditional deletion of hypothalamic Y1 receptors. The
paraventricular nucleus was chosen due to its strategic location
in the energy homeostasis circuit and because of the pres-
ence of Y1 receptor expression in this area as well as known
NPY projections to this region from the arcuate nucleus (6).
Interestingly, the effects on adipose tissue evident in germ line
Y1/mice were absent in hypothalamus-specific Y1 receptor
knock-out mice, demonstrating that the regulation of energy
homeostasis is not directly mediated through those hypotha-
lamic Y1 receptors deleted in this study but rather via other
sites. Additionally, Y1 receptors are expressed in peripheral tis-
sues, including pancreatic  cells (8), and are likely to mediate
direct effects such as inhibition of insulin secretion (23, 30).
Thus the hyperinsulinemia of Y1/ mice may be a direct
response to lack of Y1 receptors in pancreatic islet tissue and,
given that insulin is lipogenic (20, 22), may contribute to the
greater adiposity of thesemice (13). Consistent with this action,
the greatest change in adiposity was evident in Y1/ females,
which also had the greatest increase in serum insulin.
Although there is a lack of involvement of hypothalamic Y1
receptors in the regulation of energy homeostasis, these recep-
tors play a significant role in the regulation of feeding and other
feeding-related behavior. The exact reasons for food grinding
in mice are not clear (31), although it has been shown that
electrical and chemical stimulation of the hypothalamus influ-
ences the activity of masticatory trigmental neurons in the
brain stem important for jaw movement (32). It is therefore
possible that ablation of Y1 receptors in the hypothalamus leads
to altered responses to these neurons in the brainstem, leading
to increased grinding of food. Interestingly, electrical lesioning
of the paraventricular nucleus has also been found to disrupt
the initiation of maternal behavior, e.g. nest building in the rat
(33). Considering the high level of Y1 receptors in the paraven-
tricular nucleus, lack of Y1 receptors in this area might cause a
similar alteration in mice and could explain at least part of the
altered nest-building behavior seen in these conditional knock-
out mice.
Consistent with the adipose phenotype, and in contrast to
the centrally mediated effects on bone in Y2/ mice, the Y1-
dependent changes in bone did not involve those receptors
expressed in the hypothalamus (1). The importance of this
peripheral action of Y1 is heightened by the presence of Y1
receptors in osteoblastic cells, indicating, as in adipose tissue
and pancreatic  cells, the potential for direct effects. More-
over, the lack of NPY-mediated inhibition in Y1/ bone mar-
row stromal cell cultures shows, for the first time, direct regu-
lation of osteoblastic cells by NPY-mediated stimulation of Y1
receptors and is consistent with previous NPY effects in bone
cells (34, 35). The putative regulatory role of these osteoblastic
Y1 receptors is consistent with a growing understanding of the
direct effects of neural signalingmolecules on bone cell activity.
Adrenergic (36), glutamatergic (37), and cannabinoid (38)
receptors are among those neural signals recently described as
directlymediating changes in bone homeostasis. Although sim-
ilar to Y2/mice with respect to osteoblastic effects, the bone
phenotype of Y1/ mice was different from that of Y2/
mice, in that Y1 receptor knockouts displayed involvement of
the osteoclastic lineage. The greater osteoclast surface inY1/
mice, not evident in Y2/, suggests that, although there is
some evidence these receptors may share a common pathway
to control osteoblastic activity, they differ in their ability to
control cells of the osteoclast lineage. Importantly, this eleva-
tion in osteoclast indices was not sufficient to counteract the
anabolic changes.
The similarity of osteoblast phenotypes between Y1/ and
Y2/mice suggested a common signaling pathway to regulate
bone formation. In keeping with this, deletion of both the Y1
andY2 receptors did not result in additive effects on bonemass.
Therewere, however, somemicroarchitectural changes evident
in these mice, with fewer, but thicker, trabeculae compared
with single knockouts, which may relate to subtle shifts in the
balance of resorption and formation. Consistent with this, the
osteoclast surface was not elevated in Y1/Y2/ mice, sug-
gesting a Y2/-like phenotype. The dominance of the Y2/
phenotype was not complete, however, with Y1/Y2/mice
showing a more Y1/ like cortical bone phenotype.We previ-
ously showed that the effects of Y1 deletion to increase circu-
lating insulin levels and enhance adiposity in mice were no lon-
ger evident when Y2 receptors were also missing (13),
consistent with a dominantY2/-like effect on adipose home-
ostasis. Although Y1 and Y2 appear to share common pathways
in the regulation of bone and adipose tissue, discreet actions of
individual Y receptors are still apparent in these tissues.
In conclusion, this work provides clear evidence of a role for
Y1 receptors in the regulation of skeletal homeostasis and indi-
cates a direct role for these receptors to inhibit osteoblast activ-
ity. A peripheral site of action is supported by the lack of skeletal
changes after hypothalamus-specific Y1 receptor deletion as
well as the presence of Y1 receptors on osteoblasts and bone
marrow stromal cells and the abolition of the effect of NPY on
bone marrow stromal cells from Y1 receptor knock-out mice.
Although these data also demonstrate that the hypothalamic
Y1 receptors deleted in this study do not mediate the increased
Bone and Adipose Effects of Y1 Knockout
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adiposity observed in germ line Y1 receptor knock-out mice,
theymay play a role inmodulating other feeding-related behav-
iors such as grinding and nesting, revealing an altered regula-
tory axis for the homeostatic and behavioral aspects of energy
balance. The magnitude of changes evoked in bone and fat tis-
sue by germ line loss of Y1 signaling suggests that targeting such
pathways may represent effective therapeutic strategies for
both skeletal fragility and obesity.
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